Logo image of TRT

TRIO-TECH INTERNATIONAL (TRT) Stock Fundamental Analysis

USA - NYSEARCA:TRT - US8967122057 - Common Stock

6.68 USD
+0.03 (+0.45%)
Last: 11/11/2025, 8:04:00 PM
Fundamental Rating

3

TRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of TRT is average, but there are quite some concerns on its profitability. TRT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year TRT has reported negative net income.
In the past year TRT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TRT reported negative net income in multiple years.
In the past 5 years TRT always reported a positive cash flow from operatings.
TRT Yearly Net Income VS EBIT VS OCF VS FCFTRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

1.2 Ratios

TRT has a Return On Assets of -0.10%. This is comparable to the rest of the industry: TRT outperforms 48.21% of its industry peers.
TRT's Return On Equity of -0.12% is in line compared to the rest of the industry. TRT outperforms 49.11% of its industry peers.
With a Return On Invested Capital value of 0.34%, TRT perfoms like the industry average, outperforming 47.32% of the companies in the same industry.
TRT had an Average Return On Invested Capital over the past 3 years of 2.81%. This is significantly below the industry average of 10.93%.
Industry RankSector Rank
ROA -0.1%
ROE -0.12%
ROIC 0.34%
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
TRT Yearly ROA, ROE, ROICTRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

TRT has a Operating Margin (0.42%) which is in line with its industry peers.
TRT's Operating Margin has declined in the last couple of years.
TRT's Gross Margin of 25.07% is on the low side compared to the rest of the industry. TRT is outperformed by 75.89% of its industry peers.
In the last couple of years the Gross Margin of TRT has grown nicely.
Industry RankSector Rank
OM 0.42%
PM (TTM) N/A
GM 25.07%
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
TRT Yearly Profit, Operating, Gross MarginsTRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

5

2. Health

2.1 Basic Checks

TRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TRT has more shares outstanding
TRT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRT has an improved debt to assets ratio.
TRT Yearly Shares OutstandingTRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
TRT Yearly Total Debt VS Total AssetsTRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

TRT has an Altman-Z score of 4.49. This indicates that TRT is financially healthy and has little risk of bankruptcy at the moment.
TRT's Altman-Z score of 4.49 is in line compared to the rest of the industry. TRT outperforms 57.14% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that TRT is not too dependend on debt financing.
The Debt to Equity ratio of TRT (0.02) is better than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 4.49
ROIC/WACC0.03
WACC10.74%
TRT Yearly LT Debt VS Equity VS FCFTRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

TRT has a Current Ratio of 5.03. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.03, TRT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
TRT has a Quick Ratio of 4.67. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.67, TRT is doing good in the industry, outperforming 79.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.03
Quick Ratio 4.67
TRT Yearly Current Assets VS Current LiabilitesTRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1

3. Growth

3.1 Past

TRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -105.27%.
TRT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.81%.
Measured over the past years, TRT shows a small growth in Revenue. The Revenue has been growing by 1.14% on average per year.
EPS 1Y (TTM)-105.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.71%
Revenue 1Y (TTM)-13.81%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%9.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRT Yearly Revenue VS EstimatesTRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

1

4. Valuation

4.1 Price/Earnings Ratio

TRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRT Price Earnings VS Forward Price EarningsTRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

99.11% of the companies in the same industry are more expensive than TRT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.37
TRT Per share dataTRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TRIO-TECH INTERNATIONAL

NYSEARCA:TRT (11/11/2025, 8:04:00 PM)

6.68

+0.03 (+0.45%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-10 2025-11-10
Earnings (Next)02-11 2026-02-11
Inst Owners24.14%
Inst Owner Change-0.05%
Ins Owners25.82%
Ins Owner Change1.77%
Market Cap28.79M
Revenue(TTM)36.47M
Net Income(TTM)-41.00K
Analysts0
Price TargetN/A
Short Float %1.93%
Short Ratio2.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.79
P/FCF N/A
P/OCF 77.6
P/B 0.85
P/tB 0.85
EV/EBITDA 2.37
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.09
OCFY1.29%
SpS8.46
BVpS7.9
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -0.12%
ROCE 0.44%
ROIC 0.34%
ROICexc 0.66%
ROICexgc 0.66%
OM 0.42%
PM (TTM) N/A
GM 25.07%
FCFM N/A
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
ROICexc(3y)5.18%
ROICexc(5y)N/A
ROICexgc(3y)5.18%
ROICexgc(5y)N/A
ROCE(3y)3.55%
ROCE(5y)N/A
ROICexgc growth 3Y-59.08%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.08%
ROICexc growth 5YN/A
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
F-Score4
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.2
Cap/Depr 35.28%
Cap/Sales 2.65%
Interest Coverage 3.3
Cash Conversion 12.82%
Profit Quality N/A
Current Ratio 5.03
Quick Ratio 4.67
Altman-Z 4.49
F-Score4
WACC10.74%
ROIC/WACC0.03
Cap/Depr(3y)45.5%
Cap/Depr(5y)44.1%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.81%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%9.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.65%
EBIT growth 3Y-59.86%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-127.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.35%
OCF growth 3Y-44.07%
OCF growth 5Y-34.21%

TRIO-TECH INTERNATIONAL / TRT FAQ

Can you provide the ChartMill fundamental rating for TRIO-TECH INTERNATIONAL?

ChartMill assigns a fundamental rating of 3 / 10 to TRT.


What is the valuation status of TRIO-TECH INTERNATIONAL (TRT) stock?

ChartMill assigns a valuation rating of 1 / 10 to TRIO-TECH INTERNATIONAL (TRT). This can be considered as Overvalued.


What is the profitability of TRT stock?

TRIO-TECH INTERNATIONAL (TRT) has a profitability rating of 3 / 10.